Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target.

× No keyword cloud information.

29 in total

Review 1. Vaccination strategies for lymphomas.

Authors: Mohammed M Dar; Larry W Kwak
Journal: Curr Oncol Rep Date: 2003-09 Impact factor: 5.075

Review 2. Translating tumor antigens into cancer vaccines.

Authors: Luigi Buonaguro; Annacarmen Petrizzo; Maria Lina Tornesello; Franco M Buonaguro
Journal: Clin Vaccine Immunol Date: 2010-11-03

Review 3. Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.

Authors: Hyun Jun Park; Sattva S Neelapu
Journal: Br J Haematol Date: 2008-04-13 Impact factor: 6.998

Review 4. Towards an off-the-shelf vaccine therapy targeting shared B-cell tumor idiotypes.

Authors: Flavio E Baio; Larry W Kwak; Jinsheng Weng
Journal: Am J Blood Res Date: 2014-12-15

Review 5. Human tumor-associated antigens identified by monoclonal antibodies.

Authors: K E Hellström; I Hellström; J P Brown
Journal: Springer Semin Immunopathol Date: 1982

6. The assessment of anti-idiopathic antibodies as effective immunoregulatory probes in vivo.

Authors: J C Olson; C R Wagner; G A Leslie
Journal: Clin Exp Immunol Date: 1982-05 Impact factor: 4.330

Review 7. Antigen-specific vaccines for cancer treatment.

Authors: Maria Tagliamonte; Annacarmen Petrizzo; Maria Lina Tornesello; Franco M Buonaguro; Luigi Buonaguro
Journal: Hum Vaccin Immunother Date: 2014 Impact factor: 3.452

Review 8. Immunotherapy for lymphomas.

Authors: John M Timmerman
Journal: Int J Hematol Date: 2003-06 Impact factor: 2.490

9. Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.

Authors: Sivasubramanian Baskar; Carol B Kobrin; Larry W Kwak
Journal: J Clin Invest Date: 2004-05 Impact factor: 14.808

10. Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge.

Authors: P L Dunn; C A Johnson; J M Styles; S S Pease; C J Dean
Journal: Immunology Date: 1987-02 Impact factor: 7.397